Since Nuremberg, the ethics of scientific research involving human beings has for decades been the source of concern and controversy. Nowadays, profit-driven experimentation sponsored by the pharmaceutical industry has progressively migrated to the South, turning into a widespread phenomenon imbued with ethical challenges. The protection of vulnerable communities from the risks of unethical behaviour and exploitation associated with clinical trials outsourced in developing countries calls for respect on a universal basis of internationally agreed ethical standards. Failing this, massive clinical trials conducted in disregard of fundamental ethical principles and human rights may amount, in their cruellest forms, to a crime against humanity triggering the jurisdiction of the ICC over public officials of host States, individual physicians and researchers acting in their private capacity, as well as officers and directors of sponsoring corporations.
|Titolo:||Unethical Human Experimentation in Developing Countries and International Criminal Law: Old Wine in New Bottles?|
|Data di pubblicazione:||2017|
|Appare nelle tipologie:||1.1.2 Articolo su rivista con ISSN|